Datapoint: Supreme Court Cements Vascepa Patent Loss

The United States Supreme Court on Monday declined to hear Amarin’s arguments against patent loss for its fish oil derivative drug Vascepa. A federal appeals court in September upheld a lower court ruling that def...
0 Comments
© 2025 MMIT

Datapoint: Tufts, Harvard Pilgrim Name Combined Org

Following a successful merger in January, Tufts Health Plan and Harvard Pilgrim Health Care have renamed their combined organization to Point32Health, alluding to the 32 points on a compass. The new name “repres...
0 Comments
© 2025 MMIT

Datapoint: Eli Lilly to Test Emgality Against Nurtec ODT

Eli Lilly and Co. last week said it is planning a head-to-head trial for its once-monthly injectable migraine drug Emgality against Biohaven Pharmaceuticals’ Nurtec ODT, an oral therapy taken every other day. Li...
0 Comments
© 2025 MMIT

Datapoint: BCBSMI to Offer New Exchange Plan for Young Adults

Blue Cross and Blue Shield of Michigan will offer a new individual commercial product, the Preferred Value Plan, for adults under 30 on the exchange marketplace for the 2022 plan year. The plan will launch i...
0 Comments
© 2025 MMIT

Datapoint: Aetna to Expand Illinois Duals Plan

Aetna will expand its Illinois Medicare-Medicaid Alignment Initiative demonstration health plan from Chicago and central Illinois to the entire state, according to a June 11 news release. Automatic enrollment into ...
0 Comments
© 2025 MMIT

Datapoint: Nevada Gov. OKs Public Option Insurance

Following Washington’s lead, Nevada will become the second state to create a public option insurance market. Governor Steve Sisolak (D) on June 9 signed a bill that will make a public option available by 2026. T...
0 Comments
© 2025 MMIT

Datapoint: Alignment Healthcare Expands to Arizona

Medicare Advantage startup Alignment Healthcare last week said it will expand its plan offerings to Arizona in 2022. The plans will be available in two of the state’s most populous counties, Pima and Maricopa....
0 Comments
© 2025 MMIT

Datapoint: Gilead Snags Priority Review in ALL for Tecartus

Following positive Phase 2 trial data, the FDA granted Gilead Sciences’ Tecartus priority review for the treatment of adult acute lymphoblastic leukemia (ALL). The initial target date for the decision is Oct. 1. ...
0 Comments
© 2025 MMIT

Datapoint: Sentara, Cone Health Abandon Affiliation Plans

Two nonprofit health systems, Norfolk, Virginia’s Sentara Healthcare and Greensboro, North Carolina’s Cone Health, have ended their efforts to combine, according to a June 2 press release from Sentara. “Recent...
0 Comments
© 2025 MMIT

Datapoint: Zing Health to Acquire Lasso Healthcare

In an effort to expand its geographic footprint, Medicare Advantage (MA) startup Zing Health last month said it has entered an agreement to acquire Lasso Healthcare, which offers Medicare Medical Savings Account pla...
0 Comments
© 2025 MMIT